Amylin Pharmaceuticals
AcquiredPublic · San Diego, United States · Founded 1987 · $56.0M raised
- Headquarters
- San Diego, California
- Employees
- 1001–5000
- Founded
- 1987
- Business Model
- B2B
- Website
- amylin.com
- Total Funding
- $56.0M
- Last Round
- $56.0M Venture RoundJan 1989
- Rounds
- 1
- Type
- Public
- Acquired by
- Bristol-Myers Squibb CompanyJan 2012
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.
About
Amylin Pharmaceuticals was a biopharmaceutical company founded in 1987 and headquartered in San Diego, California, with a commercial manufacturing facility in Ohio. The company discovered, developed, and commercialized therapeutics for diabetes and other metabolic diseases, including the GLP-1 therapy exenatide, marketed as Byetta and Bydureon. Amylin was acquired by Bristol-Myers Squibb in 2012 as part of a landmark deal that also involved Eli Lilly.
Summary
Amylin Pharmaceuticals is a Biotech company based in San Diego, United States, founded in 1987. It has raised $56.0M in total across 1 round, most recently a $56.0M Venture Round in Jan 1989. Investors include Bristol Myers Squibb, Sequoia Capital and Sutter Hill.
Funding & Exit History
2012 (est.)
Sign up to see all 3 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/amylin-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/amylin-pharmaceuticals" alt="Amylin Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>